Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 36,345 | 35,974 | 32,494 | 29,223 | 24,199 |
| Cost of Goods | 3,245 | 3,344 | 1,799 | 382 | 518 |
| Gross Profit | 33,100 | 32,630 | 30,695 | 28,841 | 23,681 |
| Operating Expenses | 80,506 | 77,855 | 75,282 | 76,115 | 112,600 |
| Operating Income | -47,161 | -44,881 | -43,788 | -46,892 | -88,401 |
| Other Income | 1,948 | 1,838 | 727 | 0 | 6 |
| Pre-tax Income | -45,213 | -43,043 | -43,061 | -46,892 | -88,395 |
| Net Income Continuous | -45,935 | -43,043 | -43,061 | -46,892 | -88,395 |
| Net Income | $-45,935 | $-43,043 | $-43,061 | $-46,892 | $-88,395 |
| EPS Basic Total Ops | -0.42 | -0.55 | -0.60 | -0.80 | -1.52 |
| EPS Basic Continuous Ops | -0.42 | -0.55 | -0.60 | -0.80 | -1.51 |
| EPS Diluted Total Ops | -0.42 | -0.55 | -0.60 | -0.80 | -1.52 |
| EPS Diluted Continuous Ops | -0.42 | -0.55 | -0.60 | -0.80 | -1.51 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.55 | -0.60 | N/A | N/A |
| EBITDA(a) | $-46,560 | $-44,139 | $-42,968 | $-46,109 | $-87,621 |